Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Rakkar, S; Roberts, K; Towe, BF; Flores, SM; Heyd, A; Warner, J
   Moxifloxacin versus amoxycillin clavulanate in the treatment of acute maxillary sinusitis: A primary care experience
   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
   
   S. Rakkar et al., "Moxifloxacin versus amoxycillin clavulanate in the treatment of acute maxillary sinusitis: A primary care experience", INT J CL PR, 55(5), 2001, pp. 309-315
2. Obaji, A; Sethi, S
   Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?
   DRUGS & AGING
   
   A. Obaji e S. Sethi, "Acute exacerbations of chronic bronchitis - What role for the new fluoroquinolones?", DRUG AGING, 18(1), 2001, pp. 1-11
3. Abdel-Megeed, MA; Suh, DH; Abdel-Rahman, MS
   Intra-species extrapolation in risk assessment of different classes of antimicrobials
   HUMAN AND ECOLOGICAL RISK ASSESSMENT
   
   M.A. Abdel-Megeed et al., "Intra-species extrapolation in risk assessment of different classes of antimicrobials", HUM ECOL R, 7(1), 2001, pp. 15-36
4. Talbot, GH; Kennedy, DW; Scheld, WM; Granito, K
   Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis
   CLINICAL INFECTIOUS DISEASES
   
   G.H. Talbot et al., "Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis", CLIN INF D, 33(10), 2001, pp. 1668-1675
5. Ho, PL; Tse, WS; Tsang, KWT; Kwok, TK; Ng, TK; Cheng, VCC; Chan, RMT
   Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study
   CLINICAL INFECTIOUS DISEASES
   
   P.L. Ho et al., "Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: A case-control study", CLIN INF D, 32(5), 2001, pp. 701-707
6. Gerber, MA; Tanz, RR
   New approaches to the treatment of group A streptococcal pharyngitis
   CURRENT OPINION IN PEDIATRICS
   
   M.A. Gerber e R.R. Tanz, "New approaches to the treatment of group A streptococcal pharyngitis", CURR OP PED, 13(1), 2001, pp. 51-55
7. Chidiac, C
   Report on bronchitis
   MEDECINE ET MALADIES INFECTIEUSES
   
   C. Chidiac, "Report on bronchitis", MED MAL INF, 31(5), 2001, pp. 302-338
8. 
   Should we use antibiotics to treat acute bronchitis in the healthy adult or acutely exacerbated chronic bronchitis in the patient without respiratorydistress syndrome
   MEDECINE ET MALADIES INFECTIEUSES
   
   MED MAL INF, 31(5), 2001, pp. 339-343
9. 
   Should acute bronchitis in the healthy adult or chronic bronchitis in a non respiratory deficient patient be treated by antibiotherapy? Which molecule should be used? In what type of patient?
   MEDECINE ET MALADIES INFECTIEUSES
   
   MED MAL INF, 31(5), 2001, pp. 352-356
10. Gaillat, J; Dabernat, H
    Reassement of the Lille consensus on treatment of chronic bronchitis exacerbation
    MEDECINE ET MALADIES INFECTIEUSES
    
    J. Gaillat e H. Dabernat, "Reassement of the Lille consensus on treatment of chronic bronchitis exacerbation", MED MAL INF, 31(4), 2001, pp. 211-228
11. Murris-Espin, M; Mazieres, J; Heurtaux, W; Leophonte, P
    Dealing with acute bronchitis in adults without pre-existing respiratory pathology - the place of short treatment - comparison of costs.
    MEDECINE ET MALADIES INFECTIEUSES
    
    M. Murris-Espin et al., "Dealing with acute bronchitis in adults without pre-existing respiratory pathology - the place of short treatment - comparison of costs.", MED MAL INF, 31(4), 2001, pp. 229-236
12. Gaillat, J; Baranes, C; Amsellem, D; Cohen, A; Bougon, N; Riebbels, V; Chauveau, E
    Efficacy and safety of cefuroxime axetil compared to cefpodoxime proxetil in the treatment of acute exacerbations of chronic bronchitis.
    MEDECINE ET MALADIES INFECTIEUSES
    
    J. Gaillat et al., "Efficacy and safety of cefuroxime axetil compared to cefpodoxime proxetil in the treatment of acute exacerbations of chronic bronchitis.", MED MAL INF, 31(2), 2001, pp. 52-60
13. Dubreuil, C; Gehanno, P; Goldstein, F; Pancrazi, J; Timsit, C; Leblanc, F; Meunier, A; Chauveau, E
    Treatment of acute maxillary sinusitis in adult outpatients: comparison ofa five versus ten day-course of cefuroxime axetil.
    MEDECINE ET MALADIES INFECTIEUSES
    
    C. Dubreuil et al., "Treatment of acute maxillary sinusitis in adult outpatients: comparison ofa five versus ten day-course of cefuroxime axetil.", MED MAL INF, 31(2), 2001, pp. 61-69
14. Dubreuil, C; Gehanno, P; Goldstein, F; Pancrazi, J; Timsit, C; Leblanc, F; Meunier, A; Chauveau, E
    Treatment of acute maxillary sinusitis in adult outpatients: comparison ofa five versus ten day-course of cefuroxime axetil
    MEDECINE ET MALADIES INFECTIEUSES
    
    C. Dubreuil et al., "Treatment of acute maxillary sinusitis in adult outpatients: comparison ofa five versus ten day-course of cefuroxime axetil", MED MAL INF, 31(2), 2001, pp. 70-78
15. Killen, BU; Corrigan, OI
    Factors influencing drug release from stearic acid based compacts
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    B.U. Killen e O.I. Corrigan, "Factors influencing drug release from stearic acid based compacts", INT J PHARM, 228(1-2), 2001, pp. 189-198
16. Klossek, JM; Chidiac, C; Bernard, L; Dubreuil, C; Dubreuil, L; Ferrand, PA; Gehanno, P; Goldstein, F; Salamon, R; Serrano, E; Soubrier, P; Veillon, F
    Current approaches to community-acquired acute maxillary rhinosinusitis orsinusitis in France and literature review
    RHINOLOGY
    
    J.M. Klossek et al., "Current approaches to community-acquired acute maxillary rhinosinusitis orsinusitis in France and literature review", RHINOLOGY, 2001, pp. 1-38
17. Perfetto, EM; Mullins, CD; Subedi, P; Li-McLeod, J
    Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis
    CLINICAL THERAPEUTICS
    
    E.M. Perfetto et al., "Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis", CLIN THER, 23(10), 2001, pp. 1747-1772
18. Gotfried, MH; DeAbate, CA; Fogarty, C; Mathew, CP; Sokol, WN
    Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis
    CLINICAL THERAPEUTICS
    
    M.H. Gotfried et al., "Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis", CLIN THER, 23(1), 2001, pp. 97-107
19. Martin, SJ; Jung, R; Garvin, CG
    A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections
    DRUG SAFETY
    
    S.J. Martin et al., "A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections", DRUG SAFETY, 24(3), 2001, pp. 199-222
20. Takata, GS; Chan, LS; Shekelle, P; Morton, SC; Mason, W; Marcy, SM
    Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media
    PEDIATRICS
    
    G.S. Takata et al., "Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media", PEDIATRICS, 108(2), 2001, pp. 239-247
21. Rhew, DC; Weingarten, SR
    Achieving a safe and early discharge for patients with community-acquired pneumonia
    MEDICAL CLINICS OF NORTH AMERICA
    
    D.C. Rhew e S.R. Weingarten, "Achieving a safe and early discharge for patients with community-acquired pneumonia", MED CLIN NA, 85(6), 2001, pp. 1427
22. Gotfried, MH; Danzinger, LH; Rodvold, KA
    Seady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects
    CHEST
    
    M.H. Gotfried et al., "Seady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects", CHEST, 119(4), 2001, pp. 1114-1122
23. Lamb, HM; Spencer, CM
    Management of acute otitis media - Defining the role of cefuroxime axetil
    DISEASE MANAGEMENT & HEALTH OUTCOMES
    
    H.M. Lamb e C.M. Spencer, "Management of acute otitis media - Defining the role of cefuroxime axetil", DIS MANAG H, 8(6), 2000, pp. 337-353
24. Bowman, L; Faulkner, D; Lucy, L
    Differential costs and outcomes among pediatric oral antibiotic formulations identified from a large prescription database
    JOURNAL OF CHEMOTHERAPY
    
    L. Bowman et al., "Differential costs and outcomes among pediatric oral antibiotic formulations identified from a large prescription database", J CHEMOTHER, 12(1), 2000, pp. 72-78
25. Temple, ME; Nahata, MC
    Pharmacotherapy of acute sinusitis in children
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    
    M.E. Temple e M.C. Nahata, "Pharmacotherapy of acute sinusitis in children", AM J HEAL S, 57(7), 2000, pp. 663-668
26. Rudnicka, L; Szymanska, E; Walecka, I; Slowinska, M
    Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus - A report of three cases
    DERMATOLOGY
    
    L. Rudnicka et al., "Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus - A report of three cases", DERMATOLOGY, 200(2), 2000, pp. 129-131
27. Vasu, S; Adithan, C; Shashindran, CH; Asad, M; Koumaravelou, K; Topno, I
    Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil
    INDIAN JOURNAL OF MEDICAL RESEARCH
    
    S. Vasu et al., "Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil", I J MED RES, 112, 2000, pp. 104-108
28. Esposito, S; Ascione, T
    Short-course treatment for acute tonsillopharyngitis
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    S. Esposito e T. Ascione, "Short-course treatment for acute tonsillopharyngitis", INT J ANT A, 16(4), 2000, pp. 495-497
29. Novelli, A; Fallani, S; Cassetta, MI; Conti, S
    Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    A. Novelli et al., "Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics", INT J ANT A, 16(4), 2000, pp. 501-505
30. Ball, P
    New antibiotics for community-acquired lower respiratory tract infections:improved activity at a cost?
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    P. Ball, "New antibiotics for community-acquired lower respiratory tract infections:improved activity at a cost?", INT J ANT A, 16(3), 2000, pp. 263-272
31. San Joaquin, VH; Stull, TL
    Antibacterial agents in pediatrics
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    
    V.H. San Joaquin e T.L. Stull, "Antibacterial agents in pediatrics", INF DIS CL, 14(2), 2000, pp. 341
32. Pichichero, ME; Casey, JR; Mayes, T; Francis, AB; Marsocci, SM; Murphy, M; Hoeger, W
    Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    M.E. Pichichero et al., "Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies", PEDIAT INF, 19(9), 2000, pp. 917-923
33. Pichichero, ME
    Short course antibiotic therapy for respiratory infections: a review of the evidence
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    M.E. Pichichero, "Short course antibiotic therapy for respiratory infections: a review of the evidence", PEDIAT INF, 19(9), 2000, pp. 929-937
34. Douadi, Y; Lescure, X; Schmit, JL
    A new antibiotic: levofloxacine
    PRESSE MEDICALE
    
    Y. Douadi et al., "A new antibiotic: levofloxacine", PRESSE MED, 29(21), 2000, pp. 1184-1185
35. 
    Review of the Fourth Conference on Antifectious Disease Treatment of the Societe de Pathologie Infectieuse de Langue Francaise - Management of lower airway infections
    MEDECINE ET MALADIES INFECTIEUSES
    
    MED MAL INF, 30(9), 2000, pp. 566-580
36. Boulesteix, J; Olivier, C; Mselati, JC; Guillot, M; Chauveau, V; Bougon, N; Leblanc, F
    Lower respiratory tract infections in children: compared efficacy of cefuroxime axetil and cefpodoxime proxetil.
    MEDECINE ET MALADIES INFECTIEUSES
    
    J. Boulesteix et al., "Lower respiratory tract infections in children: compared efficacy of cefuroxime axetil and cefpodoxime proxetil.", MED MAL INF, 30(9), 2000, pp. 581-587
37. Gehanno, P; Goldstein, F; Gutmann, L; Klossek, JM; Deschamps, V; Dubrujeaud, G
    Efficacy of twice-daily dosing of Augmentin (R) (1 g/125 mg) in acute maxillary sinusitis
    MEDECINE ET MALADIES INFECTIEUSES
    
    P. Gehanno et al., "Efficacy of twice-daily dosing of Augmentin (R) (1 g/125 mg) in acute maxillary sinusitis", MED MAL INF, 30(11), 2000, pp. 703-713
38. Ruiz-Carretero, P; Nacher, A; Merino-Sanjuan, M; Casabo, VG
    Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil inthe rat
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    P. Ruiz-Carretero et al., "Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil inthe rat", INT J PHARM, 202(1-2), 2000, pp. 89-96
39. Robson, H; Craig, DQM; Deutsch, D
    An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    H. Robson et al., "An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. III. The use of DSC and HSDSC as means of characterising the interaction of the microspheres with buffered media", INT J PHARM, 201(2), 2000, pp. 211-219
40. Robson, H; Craig, DQM; Deutsch, D
    An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    H. Robson et al., "An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres. II. The effects of buffer composition on drug release", INT J PHARM, 195(1-2), 2000, pp. 137-145
41. Cubbon, MD; Masterton, RG
    New quinolones - a fresh answer to the pneumococcus
    Journal of antimicrobial chemotherapy
    
    M.D. Cubbon e R.G. Masterton, "New quinolones - a fresh answer to the pneumococcus", J ANTIMICRO, 46(6), 2000, pp. 869-872
42. Fogarty, CM; Bettis, RB; Griffin, TJ; Keyserling, CH; Nemeth, MA; Tack, KJ
    Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis
    Journal of antimicrobial chemotherapy
    
    C.M. Fogarty et al., "Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbations of chronic bronchitis", J ANTIMICRO, 45(6), 2000, pp. 851-858
43. Adam, D
    Short-course antibiotic therapy for infections with a single causative pathogen
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    D. Adam, "Short-course antibiotic therapy for infections with a single causative pathogen", J INT MED R, 28, 2000, pp. 13A-24A
44. Pichichero, ME
    Short courses of antibiotic in acute otitis media and sinusitis infections
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    M.E. Pichichero, "Short courses of antibiotic in acute otitis media and sinusitis infections", J INT MED R, 28, 2000, pp. 25A-36A
45. Siegel, R
    How short can courses be in lower respiratory tract infections?
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    
    R. Siegel, "How short can courses be in lower respiratory tract infections?", J INT MED R, 28, 2000, pp. 37A-47A
46. Janknegt, R
    Fluoroquinolones in acute exacerbation of chronic bronchitis and pneumonia- Drug selection by means of the SOJA method
    SOUTH AFRICAN MEDICAL JOURNAL
    
    R. Janknegt, "Fluoroquinolones in acute exacerbation of chronic bronchitis and pneumonia- Drug selection by means of the SOJA method", S AFR MED J, 90(8), 2000, pp. NIL_1
47. Guay, DRP
    Short-course antimicrobial therapy for upper respiratory tract infections
    CLINICAL THERAPEUTICS
    
    D.R.P. Guay, "Short-course antimicrobial therapy for upper respiratory tract infections", CLIN THER, 22(6), 2000, pp. 673-684
48. Moreillon, P
    Endocarditis prophylaxis revisited: experimental evidence of efficacy and new Swiss recommendations
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    
    P. Moreillon, "Endocarditis prophylaxis revisited: experimental evidence of efficacy and new Swiss recommendations", SCHW MED WO, 130(27-28), 2000, pp. 1013-1026
49. Moreno, JS; Rodriguez, J
    Use of new quinolones in respiratory tract infections
    REVISTA CLINICA ESPANOLA
    
    J.S. Moreno e J. Rodriguez, "Use of new quinolones in respiratory tract infections", REV CLIN ES, 200(12), 2000, pp. 682-684
50. Schwartz, RH
    Enhancing children's satisfaction with antibiotic therapy: A taste study of several antibiotic suspensions
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    
    R.H. Schwartz, "Enhancing children's satisfaction with antibiotic therapy: A taste study of several antibiotic suspensions", CURR THER R, 61(8), 2000, pp. 570-581
51. Laurier, C; Lachaine, J; Ducharme, A
    Economic evaluation of antibacterials in the treatment of acute sinusitis
    PHARMACOECONOMICS
    
    C. Laurier et al., "Economic evaluation of antibacterials in the treatment of acute sinusitis", PHARMACOECO, 15(1), 1999, pp. 97-113
52. Pessey, JJ; Gehanno, P; Thoroddsen, E; Dagan, R; Leibovitz, E; Machac, J; Pimentel, JM; Marr, C; Leblanc, F
    Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate
    PEDIATRIC INFECTIOUS DISEASE JOURNAL
    
    J.J. Pessey et al., "Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate", PEDIAT INF, 18(10), 1999, pp. 854-859
53. Johnson, PA; Rodriguez, HP; Wazen, JJ; Huck, W; Shan, M; Tosiello, R; Heyd, A; Echols, RM
    Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterialsinusitis
    JOURNAL OF OTOLARYNGOLOGY
    
    P.A. Johnson et al., "Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterialsinusitis", J OTOLARYNG, 28(1), 1999, pp. 3-12
54. Robson, HJ; Craig, DQM; Deutsch, D
    An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres - Part 1: The influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    H.J. Robson et al., "An investigation into the release of cefuroxime axetil from taste-masked stearic acid microspheres - Part 1: The influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres", INT J PHARM, 190(2), 1999, pp. 183-192
55. Al-Eidan, FA; McElnay, JC; Scott, MG; Kearney, MP; Troughton, KEU; Jenkins, J
    Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children
    Journal of antimicrobial chemotherapy
    
    F.A. Al-Eidan et al., "Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children", J ANTIMICRO, 44(5), 1999, pp. 709-715
56. Kays, MB; Wood, KK; Miles, DO
    In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri
    PHARMACOTHERAPY
    
    M.B. Kays et al., "In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri", PHARMACOTHE, 19(11), 1999, pp. 1308-1314
57. Read, RC
    Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia
    JOURNAL OF INFECTION
    
    R.C. Read, "Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia", J INFECTION, 39(3), 1999, pp. 171-178
58. Henry, DC; Sydnor, A; Settipane, GA; Allen, J; Burroughs, S; Cobb, MM; Holley, HP
    Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis
    CLINICAL THERAPEUTICS
    
    D.C. Henry et al., "Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis", CLIN THER, 21(7), 1999, pp. 1158-1170
59. Burke, T; Villanueva, C; Mariano, H; Huck, W; Orchard, D; Haverstock, D; Heyd, A; Church, D
    Comparison of moxifloxacin and cefuroxime axetil in the treatment of acutemaxillary sinusitis
    CLINICAL THERAPEUTICS
    
    T. Burke et al., "Comparison of moxifloxacin and cefuroxime axetil in the treatment of acutemaxillary sinusitis", CLIN THER, 21(10), 1999, pp. 1664-1677
60. Arnez, M; Radsel-Medvescek, A; Pleterski-Rigler, D; Ruzic-Sabljic, E; Strle, F
    Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans
    WIENER KLINISCHE WOCHENSCHRIFT
    
    M. Arnez et al., "Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans", WIEN KLIN W, 111(22-23), 1999, pp. 916-922
61. Dinis, PB; Monteiro, MC; Lobato, R; Martins, ML; Gomes, A
    Penetration of cefuroxime into chronically inflamed sinus mucosa
    LARYNGOSCOPE
    
    P.B. Dinis et al., "Penetration of cefuroxime into chronically inflamed sinus mucosa", LARYNGOSCOP, 109(11), 1999, pp. 1841-1847
62. Loewen, PS; Marra, CA; Marra, F
    Systematic review of the treatment of early lyme disease
    DRUGS
    
    P.S. Loewen et al., "Systematic review of the treatment of early lyme disease", DRUGS, 57(2), 1999, pp. 157-173
63. TURIK MA; JOHNS D
    COMPARISON OF CEFACLOR AND CEFUROXIME AXETIL IN THE TREATMENT OF ACUTE OTITIS-MEDIA WITH EFFUSION IN CHILDREN WHO FAILED AMOXICILLIN THERAPY
    Journal of chemotherapy
    
    M.A. Turik e D. Johns, "COMPARISON OF CEFACLOR AND CEFUROXIME AXETIL IN THE TREATMENT OF ACUTE OTITIS-MEDIA WITH EFFUSION IN CHILDREN WHO FAILED AMOXICILLIN THERAPY", Journal of chemotherapy, 10(4), 1998, pp. 306-312
64. HOPPE HL; JOHNSON CE
    OTITIS-MEDIA - FOCUS ON ANTIMICROBIAL RESISTANCE AND NEW TREATMENT OPTIONS
    American journal of health-system pharmacy
    
    H.L. Hoppe e C.E. Johnson, "OTITIS-MEDIA - FOCUS ON ANTIMICROBIAL RESISTANCE AND NEW TREATMENT OPTIONS", American journal of health-system pharmacy, 55(18), 1998, pp. 1881-1897
65. PICHICHERO ME
    EVIDENCE FOR COPATHOGENICITY AS A MECHANISM FOR BACTERIAL-RESISTANCE
    Infectious diseases in clinical practice
    
    M.E. Pichichero, "EVIDENCE FOR COPATHOGENICITY AS A MECHANISM FOR BACTERIAL-RESISTANCE", Infectious diseases in clinical practice, 7, 1998, pp. 248-253
66. El-Bouri, KW; Lewis, AM; Okeahialam, CAJ; Wright, D; Tanna, A; Joynson, DHM
    A community outbreak of invasive and non-invasive group A beta-haemolytic streptococcal disease in a town in South Wales
    EPIDEMIOLOGY AND INFECTION
    
    K.W. El-Bouri et al., "A community outbreak of invasive and non-invasive group A beta-haemolytic streptococcal disease in a town in South Wales", EPIDEM INFE, 121(3), 1998, pp. 515-521
67. Lacy, MK; Owens, RC; Xu, XW; Nicolau, DP; Quintiliani, R; Nightingale, CH
    Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    M.K. Lacy et al., "Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae", INT J ANT A, 10(4), 1998, pp. 279-283
68. PICHICHERO ME; GREEN JL; FRANCIS AB; MARSOCCI SM; MURPHY AML; HOEGER W; NORIEGA C; SORRENTO A; GOOTNICK J
    RECURRENT GROUP-A STREPTOCOCCAL TONSILLOPHARYNGITIS
    The Pediatric infectious disease journal
    
    M.E. Pichichero et al., "RECURRENT GROUP-A STREPTOCOCCAL TONSILLOPHARYNGITIS", The Pediatric infectious disease journal, 17(9), 1998, pp. 809-815
69. MEHRA S; VANMOERKERKE M; WELCK J; SVERRISSON G; SIROTIAKOVA J; MARR C; STALEY H
    SHORT-COURSE THERAPY WITH CEFUROXIME AXETIL FOR GROUP-A STREPTOCOCCALTONSILLOPHARYNGITIS IN CHILDREN
    The Pediatric infectious disease journal
    
    S. Mehra et al., "SHORT-COURSE THERAPY WITH CEFUROXIME AXETIL FOR GROUP-A STREPTOCOCCALTONSILLOPHARYNGITIS IN CHILDREN", The Pediatric infectious disease journal, 17(6), 1998, pp. 452-457
70. Dhote, R; Basse-Guerineau, AL; Bachmeyer, C; Christoforov, B; Assous, MV
    Treatment of Lyme disease
    PRESSE MEDICALE
    
    R. Dhote et al., "Treatment of Lyme disease", PRESSE MED, 27(39), 1998, pp. 2043-2047
71. GEHANNO P; SEDNAOUI P; NISSEDURGEAT S
    ACUTE OTITIS-MEDIA IN ADULTS - A COMPARATIVE-STUDY OF CEFOTIAM HEXETIL AND AMOXICILLIN-CLAVULANIC ACID EFFICACY
    Medecine et maladies infectieuses
    
    P. Gehanno et al., "ACUTE OTITIS-MEDIA IN ADULTS - A COMPARATIVE-STUDY OF CEFOTIAM HEXETIL AND AMOXICILLIN-CLAVULANIC ACID EFFICACY", Medecine et maladies infectieuses, 28(6-7), 1998, pp. 522-528
72. GEHANNO P; PESSEY JJ; DEMONTREUIL CB; DUBREUIL C; LEVY D; BERCHE P; NALET V
    CEFATRIZINE VERSUS AMOXICILLIN-CLAVULANAT E IN ACUTE MAXILLARY SINUSITIS IN ADULTS
    Medecine et maladies infectieuses
    
    P. Gehanno et al., "CEFATRIZINE VERSUS AMOXICILLIN-CLAVULANAT E IN ACUTE MAXILLARY SINUSITIS IN ADULTS", Medecine et maladies infectieuses, 28(2), 1998, pp. 208-215
73. KLEIN GL; WHALEN E; ECHOLS RM; HEYD A
    CIPROFLOXACIN VERSUS CEFUROXIME AXETIL IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE BACTERIAL SINUSITIS
    Journal of otolaryngology
    
    G.L. Klein et al., "CIPROFLOXACIN VERSUS CEFUROXIME AXETIL IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE BACTERIAL SINUSITIS", Journal of otolaryngology, 27(1), 1998, pp. 10-16
74. MACGOWAN AP; BOWKER KE
    SEQUENTIAL ANTIMICROBIAL THERAPY - PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS IN SEQUENTIAL THERAPY
    The Journal of infection
    
    A.P. Macgowan e K.E. Bowker, "SEQUENTIAL ANTIMICROBIAL THERAPY - PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS IN SEQUENTIAL THERAPY", The Journal of infection, 37, 1998, pp. 30-36
75. DAJANI AS
    CURRENT THERAPY OF GROUP-A STREPTOCOCCAL PHARYNGITIS
    Pediatric annals
    
    A.S. Dajani, "CURRENT THERAPY OF GROUP-A STREPTOCOCCAL PHARYNGITIS", Pediatric annals, 27(5), 1998, pp. 277
76. STOECKEL K; HOFHEINZ W; LANEURY JP; DUCHENE P; SHEDLOFSKY S; BLOUIN RA
    STABILITY OF CEPHALOSPORIN PRODRUG ESTERS IN HUMAN INTESTINAL JUICE -IMPLICATIONS FOR ORAL BIOAVAILABILITY
    Antimicrobial agents and chemotherapy
    
    K. Stoeckel et al., "STABILITY OF CEPHALOSPORIN PRODRUG ESTERS IN HUMAN INTESTINAL JUICE -IMPLICATIONS FOR ORAL BIOAVAILABILITY", Antimicrobial agents and chemotherapy, 42(10), 1998, pp. 2602-2606
77. GENDREL D; BOURRILLON A; BINGEN E; RAYMOND J; LILIENTHAL F; TOURON D
    5-DAY-SPIRAMYCIN VS 7-DAY-PENICILLIN-V IN THE TREATMENT OF STREPTOCOCCAL TONSILLITIS IN CHILDREN
    Clinical drug investigation
    
    D. Gendrel et al., "5-DAY-SPIRAMYCIN VS 7-DAY-PENICILLIN-V IN THE TREATMENT OF STREPTOCOCCAL TONSILLITIS IN CHILDREN", Clinical drug investigation, 13(6), 1997, pp. 338-344
78. PERITI P
    RATIONAL CHOICE OF AN ORAL BETA-LACTAM ANTIBIOTIC
    Journal of chemotherapy
    
    P. Periti, "RATIONAL CHOICE OF AN ORAL BETA-LACTAM ANTIBIOTIC", Journal of chemotherapy, 9, 1997, pp. 1-23
79. SOURGENS H; DERENDORF H; SCHIFFERER H
    PHARMACOKINETIC PROFILE OF CEFACLOR
    International journal of clinical pharmacology and therapeutics
    
    H. Sourgens et al., "PHARMACOKINETIC PROFILE OF CEFACLOR", International journal of clinical pharmacology and therapeutics, 35(9), 1997, pp. 374-380
80. DEBOCK GH; DEKKER FW; STOLK J; SPRINGER MP; KIEVIT J; VANHOUWELINGEN JC
    ANTIMICROBIAL TREATMENT IN ACUTE MAXILLARY SINUSITIS - A METAANALYSIS
    Journal of clinical epidemiology
    
    G.H. Debock et al., "ANTIMICROBIAL TREATMENT IN ACUTE MAXILLARY SINUSITIS - A METAANALYSIS", Journal of clinical epidemiology, 50(8), 1997, pp. 881-890
81. DARMSTADT GL
    ORAL ANTIBIOTIC-THERAPY FOR UNCOMPLICATED BACTERIAL SKIN INFECTIONS IN CHILDREN
    The Pediatric infectious disease journal
    
    G.L. Darmstadt, "ORAL ANTIBIOTIC-THERAPY FOR UNCOMPLICATED BACTERIAL SKIN INFECTIONS IN CHILDREN", The Pediatric infectious disease journal, 16(2), 1997, pp. 227-240
82. THORODDSEN E; MARR C; EFTHYMIOPOULOS C
    CONCENTRATION OF CEFUROXIME IN MIDDLE-EAR EFFUSION OF CHILDREN WITH ACUTE OTITIS-MEDIA
    The Pediatric infectious disease journal
    
    E. Thoroddsen et al., "CONCENTRATION OF CEFUROXIME IN MIDDLE-EAR EFFUSION OF CHILDREN WITH ACUTE OTITIS-MEDIA", The Pediatric infectious disease journal, 16(10), 1997, pp. 959-962
83. LOW DE; DESROSIERS M; MCSHERRY J; GARBER G; WILLIAMS JW; REMY H; FENTON RS; FORTE V; BALTER M; ROTSTEIN C; CRAFT C; DUBOIS J; HARDING G; SCHLOSS M; MILLER M; MCIVOR RA; DAVIDSON RJ
    A PRACTICAL GUIDE FOR THE DIAGNOSIS AND TREATMENT OF ACUTE SINUSITIS
    CMAJ. Canadian Medical Association journal
    
    D.E. Low et al., "A PRACTICAL GUIDE FOR THE DIAGNOSIS AND TREATMENT OF ACUTE SINUSITIS", CMAJ. Canadian Medical Association journal, 156(6), 1997, pp. 1-14
84. GARRAFFO R; DRUGEON HB; CHICHE D
    PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 ORAL FORMS OF CEFUROXIME AXETIL
    Fundamental and clinical pharmacology
    
    R. Garraffo et al., "PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 ORAL FORMS OF CEFUROXIME AXETIL", Fundamental and clinical pharmacology, 11(1), 1997, pp. 90-95
85. GEHANNO P; COHEN R; BARRY B
    THE TREATMENT OF ACUTE OTITIS-MEDIA - ARE ANTIBIOTICS NECESSARY - WHICH ONE FOR EMPIRIC TREATMENT - HOW LONG
    Medecine et maladies infectieuses
    
    P. Gehanno et al., "THE TREATMENT OF ACUTE OTITIS-MEDIA - ARE ANTIBIOTICS NECESSARY - WHICH ONE FOR EMPIRIC TREATMENT - HOW LONG", Medecine et maladies infectieuses, 27(4), 1997, pp. 397-407
86. PEYRAMOND D; RAFFI F; LUCHT F; LEBOUCHER G
    ANTIBIOTIC-TREATMENT OF PHARYNGO-TONSILLI TIS - INDICATIONS, THERAPEUTIC REGIMENS
    Medecine et maladies infectieuses
    
    D. Peyramond et al., "ANTIBIOTIC-TREATMENT OF PHARYNGO-TONSILLI TIS - INDICATIONS, THERAPEUTIC REGIMENS", Medecine et maladies infectieuses, 27(4), 1997, pp. 434-449
87. DELLAMONICA P; REMAN A; CHICHE D; GILET C
    ACUTE EXACERBATION OF CHRONIC-BRONCHITIS - CEFUROXIME IM, FOLLOWED BYCEFUROXIME AXETIL VERSUS CEFTRIAXONE IM
    Medecine et maladies infectieuses
    
    P. Dellamonica et al., "ACUTE EXACERBATION OF CHRONIC-BRONCHITIS - CEFUROXIME IM, FOLLOWED BYCEFUROXIME AXETIL VERSUS CEFTRIAXONE IM", Medecine et maladies infectieuses, 27(3), 1997, pp. 294-300
88. CANNONI M; BONFILS P; SEDNAOUI P; SEVENIER F; JOUBERTCOLLIN M; NISSEDURGEAT S
    CEFOTIAM HEXETIL VERSUS AMOXICILLIN CLAVU LANIC ACID FOR THE TREATMENT OF CHRONIC OTITIS-MEDIA IN ADULTS/
    Medecine et maladies infectieuses
    
    M. Cannoni et al., "CEFOTIAM HEXETIL VERSUS AMOXICILLIN CLAVU LANIC ACID FOR THE TREATMENT OF CHRONIC OTITIS-MEDIA IN ADULTS/", Medecine et maladies infectieuses, 27(11), 1997, pp. 915-921
89. BARRETT MA; LAWRENCE MJ; HUTT AJ; LANSLEY AB
    STEREOSELECTIVE ABSORPTION AND HYDROLYSIS OF CEFUROXIME AXETIL DIASTEREOMERS USING THE CACO-2 CELL MONOLAYER MODEL
    European journal of drug metabolism and pharmacokinetics
    
    M.A. Barrett et al., "STEREOSELECTIVE ABSORPTION AND HYDROLYSIS OF CEFUROXIME AXETIL DIASTEREOMERS USING THE CACO-2 CELL MONOLAYER MODEL", European journal of drug metabolism and pharmacokinetics, 22(4), 1997, pp. 409-413
90. CRAUSTEMANCIET S; DECROIX MO; FARINOTTI R; CHAUMEIL JC
    CEFPODOXIME-PROXETIL HYDROLYSIS AND FOOD EFFECTS IN THE INTESTINAL LUMEN BEFORE ABSORPTION - IN-VITRO COMPARISON OF RABBIT AND HUMAN MATERIAL
    International journal of pharmaceutics
    
    S. Craustemanciet et al., "CEFPODOXIME-PROXETIL HYDROLYSIS AND FOOD EFFECTS IN THE INTESTINAL LUMEN BEFORE ABSORPTION - IN-VITRO COMPARISON OF RABBIT AND HUMAN MATERIAL", International journal of pharmaceutics, 157(2), 1997, pp. 153-161
91. STEIN GE; SCHOOLEY S; WALKER RD; STRENKOSKINIX L
    PHARMACODYNAMIC ACTIVITY OF 5 ORAL CEPHALOSPORINS AGAINST HAEMOPHILUS-INFLUENZAE
    Pharmacotherapy
    
    G.E. Stein et al., "PHARMACODYNAMIC ACTIVITY OF 5 ORAL CEPHALOSPORINS AGAINST HAEMOPHILUS-INFLUENZAE", Pharmacotherapy, 17(2), 1997, pp. 235-241
92. LORENZOLAMOSA ML; CUNA M; VILAJATO JL; TORRES D; ALONSO MJ
    DEVELOPMENT OF A MICROENCAPSULATED FORM OF CEFUROXIME AXETIL USING PH-SENSITIVE ACRYLIC POLYMERS
    Journal of microencapsulation
    
    M.L. Lorenzolamosa et al., "DEVELOPMENT OF A MICROENCAPSULATED FORM OF CEFUROXIME AXETIL USING PH-SENSITIVE ACRYLIC POLYMERS", Journal of microencapsulation, 14(5), 1997, pp. 607-616
93. POOLE MD
    ANTIMICROBIAL THERAPY FOR SINUSITIS
    Otolaryngologic clinics of North America
    
    M.D. Poole, "ANTIMICROBIAL THERAPY FOR SINUSITIS", Otolaryngologic clinics of North America, 30(3), 1997, pp. 331
94. GHIA M; LOTTI R; TRAVERSO C; MATTIOLI F; MARTELLI A
    PENETRATION OF ORAL CEFUROXIME AXETIL INTO THE HUMAN AQUEOUS-HUMOR
    Ophthalmologica
    
    M. Ghia et al., "PENETRATION OF ORAL CEFUROXIME AXETIL INTO THE HUMAN AQUEOUS-HUMOR", Ophthalmologica, 211(4), 1997, pp. 229-231
95. SCAGLIONE F; DEMARTINI G; ARCIDIACONO MM; PINTUCCI JP
    OPTIMUM TREATMENT OF STREPTOCOCCAL PHARYNGITIS
    Drugs
    
    F. Scaglione et al., "OPTIMUM TREATMENT OF STREPTOCOCCAL PHARYNGITIS", Drugs, 53(1), 1997, pp. 86-97
96. VANDENBRANDE P; VONDRA V; VOGEL F; SCHLAEFFER F; STALEY H; HOLMES C
    SEQUENTIAL THERAPY WITH CEFUROXIME FOLLOWED BY CEFUROXIME AXETIL IN COMMUNITY-ACQUIRED PNEUMONIA
    Chest
    
    P. Vandenbrande et al., "SEQUENTIAL THERAPY WITH CEFUROXIME FOLLOWED BY CEFUROXIME AXETIL IN COMMUNITY-ACQUIRED PNEUMONIA", Chest, 112(2), 1997, pp. 406-415
97. COLLINS JJ
    TREATMENT OF ERYTHEMA MIGRANS
    Annals of internal medicine
    
    J.J. Collins, "TREATMENT OF ERYTHEMA MIGRANS", Annals of internal medicine, 126(5), 1997, pp. 408-408
98. GOOCH WM; BLAIR E; PUOPOLO A; PASTER RZ; SCHWARTZ RH; MILLER HC; SMYRE HL; YETMAN R; GIGUERE GG; COLLINS JJ
    EFFECTIVENESS OF 5 DAYS OF THERAPY WITH CEFUROXIME AXETIL SUSPENSION FOR TREATMENT OF ACUTE OTITIS-MEDIA
    The Pediatric infectious disease journal
    
    W.M. Gooch et al., "EFFECTIVENESS OF 5 DAYS OF THERAPY WITH CEFUROXIME AXETIL SUSPENSION FOR TREATMENT OF ACUTE OTITIS-MEDIA", The Pediatric infectious disease journal, 15(2), 1996, pp. 157-164
99. CLUZEL R; PORTIER H; MODAI J
    PREDICTIVE VALUE OF IN-VITRO SUSCEPTIBILI TY TESTING ON CLINICAL OUTCOME OF BACTERIAL PNEUMONIA TREATED WITH CEFUROXIME AXETIL
    Pathologie et biologie
    
    R. Cluzel et al., "PREDICTIVE VALUE OF IN-VITRO SUSCEPTIBILI TY TESTING ON CLINICAL OUTCOME OF BACTERIAL PNEUMONIA TREATED WITH CEFUROXIME AXETIL", Pathologie et biologie, 44(3), 1996, pp. 217-223
100. HUTT AJ; OGRADY J
     DRUG CHIRALITY - A CONSIDERATION OF THE SIGNIFICANCE OF THE STEREOCHEMISTRY OF ANTIMICROBIAL AGENTS
     Journal of antimicrobial chemotherapy
     
     A.J. Hutt e J. Ogrady, "DRUG CHIRALITY - A CONSIDERATION OF THE SIGNIFICANCE OF THE STEREOCHEMISTRY OF ANTIMICROBIAL AGENTS", Journal of antimicrobial chemotherapy, 37(1), 1996, pp. 7-32